Therapy Clinical Trial
Official title:
"Microbotox" Versus Intramuscular Botulinum Toxin in Lower Face Rejuvenation: A Crossover Clinical Trial
The purpose of this study is to evaluate the efficiency of the intradermal injection of botulinum toxin in lower face rejuvenation. The study will also compare this intervention with the "Nefertiti Lift" intramuscular injection technique.
The abobotulinumtoxinA will be used for the intervention. The abobotulinumtoxinA will be
prepared by adding 2.5 cc of normal saline to a 500-unit Dysport© (Ipsen Ltd, Berks, UK)
vial. Further dilution to the appropriate Microbotox concentration will be done in the
syringe itself. Each 1mL syringe of Microbotox solution will contain 20-28 units of
onabotulinumtoxinA per mL of solution.
Preinjection frontal, oblique and lateral patient pictures will be taken (at rest and with
contraction)
Injection points:
A series of 100-150 intradermal microdroplets injection points 1 cm apart will be delivered
in the lower face. The area to be injected is bounded by a line 3 fingerbreadths above and
parallel to the lower border of the mandible, 1 fingerbreadth posterior to the depressor
anguli oris, and all the way down over the cervicomental angle and anterior neck to the upper
border of the clavicle, and posteriorly to the anterior border of the sternocleidomastoid.
In the average patient, 2 syringes of 28 units per mL of microbotox will be used to cover the
entire area.
In heavier necks, 3 syringes of 28 units per mL will be used. In thinner necks, 2 syringes of
20 units per mL will be used.
Follow up will be done at 15 days for post injection pictures. A total of 15 patients will be
recruited
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03650543 -
Effect of the CYP2C19 Polymorphism in Helicobacter Pylori Eradication
|
Phase 4 | |
| Recruiting |
NCT05788861 -
Invasive Group A Streptococcal Infection
|
||
| Completed |
NCT03712748 -
Online Imaginal Exposure
|
N/A | |
| Completed |
NCT01031667 -
Synergistic Effect of Combination Therapy With Cilostazol and Probucol on Plaque Stabilization and Lesion Regression: Serial Intravascular Ultrasound and Virtual Histology Study(SECURE Study)
|
Phase 4 | |
| Recruiting |
NCT00226408 -
Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha Interferon
|
Phase 3 | |
| Completed |
NCT05104957 -
Evaluation of the Kinesiology Taping Effectiveness in the Treatment of Lumbar Spine Pain
|
N/A | |
| Recruiting |
NCT06137053 -
Effect of Telitacicept on Transitional Regulatory B Cells in Patients With Systemic Lupus Erythematosus
|
||
| Completed |
NCT01023126 -
Obesity and Psychotherapy as an Alternative to Treatment
|
N/A | |
| Recruiting |
NCT06040515 -
Probiotic After Acute Colonic Diverticulitis
|
||
| Recruiting |
NCT05340738 -
AI-Based Fidelity Feedback to Enhance CBT
|
N/A | |
| Active, not recruiting |
NCT02455609 -
Intrathecal Ketamine, Dexmedetomidine and Both With Bupivacaine for Postoperative Abdominal Cancer Surgery Pain
|
Phase 2/Phase 3 | |
| Completed |
NCT05261503 -
Investigation of the Effectiveness of Environmental Enrichment-Based Intervention in Preterm Infants
|
N/A | |
| Completed |
NCT04926311 -
Efficiency of Speech and Language Intervention on Achievement of Children With Developmental Language Disorder
|
||
| Recruiting |
NCT03721783 -
Infant and Child European Cryoablation Project ICECaP
|
||
| Recruiting |
NCT03283839 -
Consequences of Temporomandibular Disorder on Balance Control
|
N/A | |
| Recruiting |
NCT05901558 -
Strategies for Toddler ASD With Remote-therapy (STAR) Model for ASD
|
N/A | |
| Completed |
NCT03177863 -
Expectancy as Alternative to Treatment for Cervical Intraepithelial Neoplasia Grade 2 Among Women 25 - 30 Years of Age
|
N/A | |
| Recruiting |
NCT06146972 -
Efficacy Study of Iguratimod Combined With Tofacitab in Patients With RF Positive/Negative Rheumatoid Arthritis
|
Phase 4 | |
| Recruiting |
NCT03161249 -
Psychoeducative Treatment of FEP With Mobile Training
|
N/A | |
| Recruiting |
NCT04490317 -
CARbon monoxidE intoxiCatiOn in Korea: Prospective Cohort (CARE CO Cohort)
|